Business · 24/04/2001Updated: 10/17/2026 · 1 min read
FDA Issues Interim Rule to Enhance Child Safety in Clinical Trials
Summary
The Food and Drug Administration (FDA) is introducing new safeguards to protect children participating in clinical trials of FDA-regulated products, in compliance with the Children's Health Act of 2000, amid growing pediatric research initiatives.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →